Don’t overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
0 1 min 11 mths



The drug stock is higher over the past month while the S&P 500 has pulled back sharply.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *